ScieGen Pharmaceuticals Inc. - NAI
FDA Inspections Database

ScieGen Pharmaceuticals Inc. - NAI

FDA Inspections Database

U.S. FDA inspection classifications and citation records from the official FDA inspection database.

NAI · No Action Indicated United States
  • Total Records 7
  • Latest Inspection 2025-12-19
  • Data Source U.S. FDA
  • Last Updated 2026-02-26

14

All
View

7

NAI
View

6

VAI
View

1

OAI
View
Company Overview

Company

ScieGen Pharmaceuticals Inc. - NAI

Country

U.S.A

Website

Visit Website

Email

info@sciegenpharm.com

Social Profiles

Company Snapshot

ScieGen Pharmaceuticals Inc. - NAI

20 Davids Driv, Hauppauge, NY 11788

U.S.A

sciegenpharm.com/ info@sciegenpharm.com View on Map
FDA Inspections Timeline (7 records)
2025
19 Dec
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2025-12-19

FMD Date

2026-02-26

Fiscal Year

2026

State

New York

Hauppauge, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2026
Citations: No

2024
20 Feb
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2024-02-20

FMD Date

2024-03-04

Fiscal Year

2024

State

New York

Hauppauge, United States

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2024
Citations: No

2018
20 Apr
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2018-04-20

FMD Date

2018-05-23

Fiscal Year

2018

State

New York

Hauppauge, United States

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2018
Citations: No

2018
16 Mar
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2018-03-16

FMD Date

2018-05-09

Fiscal Year

2018

State

New York

Hauppauge, United States

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2018
Citations: No

2018
14 Mar
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2018-03-14

FMD Date

-

Fiscal Year

2018

State

New York

Hauppauge, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2018
Citations: No

2013
18 Sep
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2013-09-18

FMD Date

-

Fiscal Year

2013

State

New York

Hauppauge, United States

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2013
Citations: No

2013
02 Apr
No Action Indicated NAI

Legal Name

Sciegen Pharmaceuticals Inc

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2013-04-02

FMD Date

-

Fiscal Year

2013

State

New York

Hauppauge, United States

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2013
Citations: No

Related Databases
  • FDA Inspections
    14 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    266 View
  • Drug Prices in Switzerland
    0 View
Classification Breakdown
7 total
  • NAI (No Action Indicated)
Official Source

All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.

Visit FDA.gov
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Location

Hauppauge, New York, United States

Inspection Info

Fiscal Year: 2026
Citations: No

100% Official Data

Directly from the U.S. FDA inspection database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

FDA inspection data is compiled from publicly available U.S. FDA inspection classification records.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit